{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:07:09Z","timestamp":1784696829005,"version":"3.55.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Clinically severe subacute thyroiditis (SAT) requires high cumulative doses of systemic steroids. The aim of the DLISAT study was to assess efficacy and safety of intrathyroidal dexamethasone and lidocaine injections (DLI) in comparison to standard oral steroid therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total number of 60 patients were included in the study, among whom 30 were treated with DLI (study group, SG) and 30 were treated with oral prednisone (control group, CG). In all SG patients, a dose of 4mg of dexamethasone with 1 ml of 2% lidocaine, was injected into each affected thyroid lobe. On the basis of clinical and biochemical results, the doses were repeated every 2\u20135 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Excellent response was observed in all SG patients, with no side effects except for injection-related discomfort. After the first injection, pain decrease and improvement in ESR, CRP, and thyroid parameters were observed. The mean cumulative dose of dexamethasone was 49.7 mg. The mean therapy period was 26.4 days. In CG, the mean therapy period was 118.9 days and the cumulative dose was 255.2 mg (1702.17 mg of prednisone).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>DLI was demonstrated to be significantly more beneficial than standard oral steroid therapy, which is especially important for patients with high risk of steroid-related complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1820684","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:45:01Z","timestamp":1784695501000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of intrathyroidal dexamethasone therapy in severe subacute thyroiditis \u2013 a real-world prospective single center study"],"prefix":"10.3389","volume":"17","author":[{"given":"Magdalena","family":"Stasiak","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolic Diseases, Polish Mother\u2019s Memorial Hospital - Research Institute","place":["Lodz, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Rosi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolic Diseases, Polish Mother\u2019s Memorial Hospital - Research Institute","place":["Lodz, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart\u0142omiej","family":"Stasiak","sequence":"additional","affiliation":[{"name":"Institute of Information Technology, Lodz University of Technology","place":["Lodz, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Michalak","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolic Diseases, Polish Mother\u2019s Memorial Hospital - Research Institute","place":["Lodz, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Lewi\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolic Diseases, Polish Mother\u2019s Memorial Hospital - Research Institute","place":["Lodz, Poland"]},{"name":"Department of Endocrinology and Metabolic Diseases, Medical University of Lodz","place":["Lodz, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadiusz","family":"Zygmunt","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolic Diseases, Polish Mother\u2019s Memorial Hospital - Research Institute","place":["Lodz, Poland"]},{"name":"Department of Endocrinology and Metabolic Diseases, Medical University of Lodz","place":["Lodz, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9020534","article-title":"Subacute thyroiditis is associated with HLA-B18:01, -DRB101 and -C*04:01\u2014the significance of the new molecular background","volume":"9","author":"Stasiak","year":"2020","journal-title":"J Clin Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2012.01.003","article-title":"Subacute, silent, and postpartum thyroiditis","volume":"96","author":"Samuels","year":"2012","journal-title":"Med Clin North Am"},{"key":"B3","article-title":"Clinical characteristics of subacute thyroiditis is different than it used to be\u2014current state based on 15 years own material","volume":"39","author":"Stasiak","year":"2019","journal-title":"Neuro Endocrinol Lett"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/794943","article-title":"Subacute thyroiditis: Clinical presentation and long term outcome","volume":"2014","author":"Alfadda","year":"2014","journal-title":"Int J Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021799","article-title":"Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted county, Minnesota, study","volume":"88","author":"Fatourechi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26924","article-title":"Painless subacute thyroiditis in a patient with acute COVID-19 infection: A transient event","volume":"14","author":"Dolkar","year":"2022","journal-title":"Cureus"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24949","article-title":"A case of painless subacute thyroiditis presenting as fever of unknown origin","volume":"14","author":"Neupane","year":"2022","journal-title":"Cureus"},{"key":"B8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13256-018-1590-6","article-title":"Asymptomatic thyroiditis presenting as pyrexia of unknown origin: A case report","volume":"12","author":"Dalugama","year":"2018","journal-title":"J Med Case Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12902-023-01313-6","article-title":"Subacute thyroiditis presenting as simple acute headache was misdiagnosed as meningitis: case report and literature review","volume":"23","author":"Huang","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-021-09648-y","article-title":"New aspects in the pathogenesis and management of subacute thyroiditis","volume":"22","author":"Stasiak","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00003","article-title":"Sonographic pattern of subacute thyroiditis is HLA-dependent","volume":"10","author":"Stasiak","year":"2019","journal-title":"Front Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.59556\/japi.72.0573","article-title":"Responsible use of oral corticosteroids in people with comorbid diabetes: an expert consensus","volume":"72","author":"Saboo","year":"2024","journal-title":"J Assoc Physicians India"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1055\/a-1148-2260","article-title":"Successful management of recurrent subacute thyroiditis by adding colchicine to glucocorticoid treatment: A case series study","volume":"52","author":"Tian","year":"2020","journal-title":"Horm Metab Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2014.03.013","article-title":"A novel treatment for subacute thyroiditis: administration of a mixture of lidocaine and dexamethasone using an insulin pen","volume":"89","author":"Ma","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000542","article-title":"Real-world effect of the treatment for painful subacute thyroiditis: The combined injection of lidocaine and triamcinolone using an insulin pen","volume":"67","author":"Hu","year":"2023","journal-title":"Arch Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/jum.16054","article-title":"Ultrasound-guided capsular thyroid injection therapy with dexamethasone and lidocaine mixture for subacute thyroiditis: A single-center study","volume":"42","author":"Huo","year":"2023","journal-title":"J Ultrasound Med"},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.36740\/WLek202108125","article-title":"Painful subacute thyroiditis treatment approach","volume":"74","author":"Forkert","year":"2021","journal-title":"Wiad Lek"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-019-0415-y","article-title":"Thyroid primary and metastatic Malignant tumors of poor prognosis may mimic subacute thyroiditis - time to change the diagnostic criteria: case reports and a review of the literature","volume":"19","author":"Stasiak","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-1122-3","article-title":"Comparison of the therapeutic effects of prednisolone and nonsteroidal anti-inflammatory drugs in patients with subacute thyroiditis","volume":"55","author":"Sato","year":"2017","journal-title":"Endocrine"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.0459","article-title":"Initial treatment with 15 mg of prednisolone daily is sufficient for most patients with subacute thyroiditis in Japan","volume":"23","author":"Kubota","year":"2013","journal-title":"Thyroid"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1820684\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:45:09Z","timestamp":1784695509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1820684\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":21,"alternative-id":["10.3389\/fendo.2026.1820684"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1820684","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"1820684"}}